LICENSED PHARMACY & UK-LICENSED DOCTORS · FREE DISCREET DELIVERY

DARIDOREXANT · IDORSIA · ONCE-NIGHTLY TABLET

QUVIVIQTABLETS

Daridorexant for long-term insomnia, prescribed online by UK clinicians after a free sleep assessment.

Quviviq tablets
1NIGHTLY TABLET
25/50MG STRENGTHS
3MONTH REVIEW
NICERECOMMENDED

Free discreet delivery

*Trial results are group averages achieved under study conditions; individual results vary.

Quviviq is the first medicine licensed in the UK specifically for long-term insomnia — and the first insomnia treatment recommended by NICE. Instead of sedating your brain the way traditional sleeping pills do, it blocks orexin, the chemical signal that keeps you awake — helping you fall asleep faster, stay asleep longer, and feel more functional the next day.

ABOUT THE MEDICATION

WHAT IS QUVIVIQ?

Quviviq is the brand name for daridorexant, developed by Idorsia. It belongs to a new class of sleep medicines — dual orexin receptor antagonists (DORAs) — and is licensed for adults whose insomnia has lasted at least three months and has a considerable impact on daytime functioning.

That licence wording matters: every previous prescription sleep medicine in the UK was restricted to short courses. Quviviq is the only one licensed for the long-term condition chronic insomnia actually is.

KEY FACTS

  • ONCE NIGHTLY

    A once-nightly tablet in two strengths, 25 mg and 50 mg, taken within 30 minutes of going to bed.

  • MHRA-LICENSED

    Licensed for long-term insomnia — every previous prescription sleep medicine in the UK was restricted to short courses.

  • NICE-RECOMMENDED

    NICE recommended it (TA922) as an option where CBT-I has failed, is unsuitable or is unavailable.

  • NOT A BENZO OR Z-DRUG

    It is not a benzodiazepine, not a Z-drug, and — unlike both — not a controlled drug in the UK.

  • NO DEPENDENCE IN TRIALS

    On stopping, trials found no rebound insomnia and no withdrawal signs.

How it works

Online consultation questionnaire on a phone
01

FREE SLEEP ASSESSMENT

Complete a free online sleep assessment.
Messages from your doctor in your account
02

PRESCRIBER REVIEW

If Quviviq is clinically appropriate for you, our GPhC-registered pharmacy will dispense your treatment.
From Mars monthly treatment pack
03

FREE TRACKED DELIVERY

Free, discreet, tracked delivery — with reviews built in.

QUVIVIQ®

Quviviq tablets
  • Once nightly within 30 minutes of bed
  • Licensed for long-term insomnia
  • Blocks the orexin wake signal
  • Not a controlled drug in the UK

How Quviviq Works

A Different Idea of a Sleeping Pill

Traditional sleeping tablets work by amplifying GABA, the brain's general 'brake' — they sedate the whole brain, which is why they cause grogginess, memory fuzz and dependence.

Quviviq starts from a different question: what if the problem isn't too little sleepiness, but too much wakefulness?

Turning Down the Wake Signal

Orexin is the neuropeptide that drives wakefulness — the biological 'stay awake' signal. In many people with chronic insomnia, this wake drive stays inappropriately switched on at night (that 'tired but wired' feeling). Daridorexant blocks both orexin receptors, turning the wake signal down so natural sleep can happen.

In Practice

The Practical Consequences

  • Sleep architecture is preserved

    Quviviq doesn't force sedation; polysomnography in its trials showed the normal proportions of sleep stages, rather than the altered sleep traditional hypnotics produce.

  • Designed to be gone by morning

    Daridorexant's duration of action was deliberately engineered to cover the night and clear by waking, minimising next-day hangover.

  • Daytime functioning was a trial endpoint

    Uniquely for an insomnia medicine, its phase 3 programme measured and demonstrated improvement in daytime sleepiness and functioning, not just nighttime numbers.

Dosing & How to Take

HOW TO TAKE QUVIVIQ®

01

Timing

Take one tablet within 30 minutes of going to bed — and only on nights when you can stay in bed for at least 7 hours before needing to be active.

02

Food

It can be taken with or without food, but a large or late heavy meal delays how quickly it works — if you've eaten late, expect a slower onset that night.

03

Missed dose

Skip it — never take Quviviq in the middle of the night or double up the next night. One untreated night is fine.

04

Duration

Licensed for long-term use, with treatment reviewed at 3 months and regularly thereafter — continuation is a decision, not a default.

Side Effects

FULL PICTURE &
HOW TO MANAGE THEM

Quviviq was generally well tolerated in trials, with discontinuation rates similar to placebo. The profile:

COMMON — UP TO 1 IN 10

SIDE EFFECTS

Headache, sleepiness or fatigue, dizziness, nausea

WHAT TO DO

Usually mild and settling within the first weeks; take only with a full 7-hour sleep window; report persistent daytime drowsiness — a dose review may help

UNCOMMON — UP TO 1 IN 100

SIDE EFFECTS

Sleep paralysis (brief inability to move or speak when falling asleep or waking), hypnagogic/hypnopompic hallucinations (vivid perceptions at sleep-wake transitions)

WHAT TO DO

Unsettling but not dangerous; mainly in the first weeks; report them — dose reduction or stopping resolves them

RARE / CLASS EFFECTS

SIDE EFFECTS

Symptoms resembling mild cataplexy (sudden brief muscle weakness), complex sleep behaviours, worsening of depression or suicidal thoughts in those with existing depression

WHAT TO DO

Stop and contact us promptly; mental health history is screened at consultation and monitored

Driving and machinery: don't drive or operate machinery if you feel drowsy the morning after a dose. Caution is greatest in the first weeks, after any dose increase, and on nights with fewer than 7 hours in bed. If morning drowsiness persists, tell us — it's usually fixable with timing or dose. Report suspected side effects via the MHRA Yellow Card scheme. Our pharmacists are available throughout treatment.

The Evidence

Clinical Evidence: What the Trials Show

The pivotal phase 3 programme

1,850+

adults with diagnosed insomnia disorder, in two randomised, double-blind, placebo-controlled phase 3 trials

In the pivotal study of 930 participants, the 50 mg dose at three months significantly reduced the time taken to fall asleep and time spent awake during the night versus placebo (improvements from baseline of roughly half an hour on both measures), increased self-reported total sleep time, and — the first-in-class result — significantly improved daytime sleepiness and functioning scores (IDSIQ).

Long-term extension

12

months of continuous use

A 40-week extension (giving up to 12 months of continuous use) supported maintained effect and a stable safety profile, with no evidence of tolerance — effects did not fade with time, the failure mode of traditional hypnotics.

Discontinuation findings

On stopping, trials found no rebound insomnia (sleep worse than before treatment) and no withdrawal signs — the two hallmarks of dependence that constrain benzodiazepines and Z-drugs to short courses.

Trial results are group averages achieved under study conditions; individual results vary. NICE's recommendation includes a 3-month effectiveness review, which our service mirrors.

Dosing
Schedule

Quviviq comes as a once-nightly tablet in two strengths, 25 mg and 50 mg, taken within 30 minutes of going to bed.

STRENGTH
WHO IT'S FOR
NOTES
50 mg nightly
Standard adult dose
The dose with the strongest trial results
25 mg nightly
Moderate liver impairment; alongside moderate CYP3A4-inhibiting medicines; where 50 mg isn't tolerated
Effective at group level with more moderate results

Progress Over Time

What to Expect:
Your Quviviq Timeline

  • Night 1 onward

    Quviviq works from the first dose — there's no build-up period. Effect within the first nights is normal, though it can strengthen over the first weeks.

  • Weeks 1–4

    Falling asleep faster and fewer prolonged night wakings are typically the first changes patients notice; any early side effects usually settle in this window.

  • Months 1–3

    The daytime benefit — less morning heaviness, better concentration — tends to be the slower-building, more valued change. Keep a simple sleep diary.

  • Month 3 review

    Built into your treatment, in line with NICE: if Quviviq is clearly helping, treatment continues with regular checks; if it isn't, we stop it.

The Comparison

HOW QUVIVIQ
COMPARES

QUVIVIQ
Z-DRUGS (E.G. ZOPICLONE)
SEDATING ANTIHISTAMINES
Mechanism
Blocks orexin wake signal
GABA sedation
Histamine blockade
Licence
Long-term insomnia
Up to ~4 weeks
Short-term use
Dependence
No evidence in trials; not controlled in UK
Recognised risk; controlled drug
Rapid tolerance
Next day
Engineered to clear by morning; daytime function improved in trials
Hangover effect common
Grogginess common
Stopping
No taper needed; no rebound in trials
Withdrawal and rebound insomnia recognised
Rebound sleeplessness common

RELATED TREATMENTS.

Real medication. Real doctors. No inflated prices. Just results.

Wegovy tablet in an astronaut glove
New — MHRA approved June 2026

Wegovy Tablets

(oral semaglutide)

New for 2026. The UK's first once-daily GLP-1 weight loss tablet, MHRA-approved in June 2026. The same active ingredient as the Wegovy injection, with comparable weight loss in trials — no needles required.

Viagra tablet in an astronaut glove

Viagra

(sildenafil)

The original ED tablet. Sildenafil is taken about 1 hour before sex, only when needed, and comes in 25, 50 and 100 mg strengths. Prescribed online after a clinician review.

Finasteride tablet in an astronaut glove

Finasteride

(generic Propecia)

Finasteride is a prescription drug that has been medically proven to treat hair loss in men. One daily tablet with the same active ingredient as Propecia.

Valaciclovir tablet in an astronaut glove

Valaciclovir

(Valtrex)

Daily suppressive treatment for people already diagnosed with herpes, to help lessen the frequency of outbreaks and reduce the risk of passing the virus on.

Price includes medication only, if prescribed. An active FromMars membership is required and billed separately. Membership does not include or guarantee a prescription; medication is not available without a membership.

Drug Interactions

Interactions With Other Medicines

  • Alcohol

    Additive effect on sleepiness and impairment — avoid combining, and never use alcohol as a 'top-up' on a bad night. Alcohol also fragments sleep, working directly against treatment.

  • Other Sedating Medicines

    Benzodiazepines, Z-drugs, opioids, sedating antihistamines and some antidepressants add to CNS depression — existing sleep medicines should be reviewed and tapered appropriately before starting, and dose adjustments may be needed. List everything in your consultation.

  • CYP3A4 Medicines

    Strong CYP3A4 inducers (e.g. rifampicin, St John's Wort, carbamazepine) can make Quviviq ineffective — declare herbal products too.

WARNINGS

Who Should Not Take Quviviq

  • NOT WITH NARCOLEPSY

    Blocking orexin (the signal narcolepsy already lacks) can worsen its symptoms.

  • NOT ALONGSIDE STRONG CYP3A4-INHIBITING MEDICINES

    E.g. clarithromycin, itraconazole, ritonavir — these raise daridorexant levels substantially; moderate inhibitors (e.g. erythromycin, diltiazem — and grapefruit juice in the evening) cap the dose at 25 mg.

  • NOT RECOMMENDED IN SEVERE LIVER IMPAIRMENT

    Use 25 mg in moderate impairment. Not recommended in pregnancy or breastfeeding.

  • CAUTION WITH A HISTORY OF DEPRESSION, PSYCHIATRIC ILLNESS OR SUBSTANCE MISUSE

    Or compromised breathing during sleep (untreated sleep apnoea, severe COPD) — screened in every consultation.

  • NOT LICENSED UNDER 18

    Licensed for adults whose insomnia has lasted at least three months and has a considerable impact on daytime functioning.

Lifestyle

Getting the Most From Treatment

Quviviq lowers the wake signal; your habits decide what fills the space. The combination that performs best in practice:

  1. 01

    A Fixed Wake Time

    A fixed wake time seven days a week — the single most powerful insomnia habit, and it makes the medicine's job easier.

  2. 02

    Caffeine, Alcohol, Screens

    Caffeine cut-off by early afternoon; alcohol modest and not nightly; screens down in the final hour.

  3. 03

    Bed Is for Sleep

    If you're awake more than ~20 minutes, get up, do something dull in low light, return when sleepy — this retrains the association Quviviq can't retrain for you.

  4. 04

    Take CBT-I If You Can

    If you can access CBT-I (NHS, apps, or private), take it — it's complementary, not competing, and it's what makes eventually stopping medication realistic.

Stopping Treatment

Stopping Quviviq

One of Quviviq's genuine advantages: in trials, stopping produced no rebound insomnia and no withdrawal effects, and it requires no taper — unlike benzodiazepines and Z-drugs, whose discontinuation can be harder than the insomnia they treated.

Practical approach: after a sustained period of good sleep (and ideally with CBT-I skills in place), a planned stop with a review two to four weeks later.

If Insomnia Returns

If sleep holds, you're done; if chronic insomnia reasserts itself, restarting is straightforward — it's a relapsing condition, not a personal failure.

Houston,
we have answers.

Sources

References

  1. 1.  Mignot E et al. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials. Lancet Neurol 2022;21:125–139.
  2. 2.  Kunz D et al. Long-term safety and tolerability of daridorexant in patients with insomnia disorder (40-week extension). CNS Drugs 2023;37:93–106.
  3. 3.  NICE TA922: Daridorexant for treating long-term insomnia (2023).
  4. 4.  Quviviq Summary of Product Characteristics (SmPC), electronic medicines compendium (emc), current version.
  5. 5.  NICE guideline/CKS: Insomnia — assessment and management.

Pricing

Cost & What's Included

Quviviq is priced at [£X] per 30-tablet pack (one month), the same price at either strength.

  • Prescriber assessment
  • Ongoing pharmacist support
  • 3-month effectiveness review
  • Free tracked delivery
  • No subscription lock-in
30-tablet pack25 mg or 50 mg

READY TO START?

GET QUVIVIQ®
TODAY

Complete a free online sleep assessment and, if Quviviq is clinically appropriate for you, our GPhC-registered pharmacy will dispense your treatment with free, discreet, tracked delivery and reviews built in.